BGC

ANALYST NOTE: BGC Group, Inc. (BGC) Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

Classification: CONFIRMED-ACTIVE

• Conservative Entry: $11.03
• Current Price: $12.05
• Extension: +9.2% above conservative entry
• Breakout Level: $11.03 (implied by conservative entry)

The price action is currently in a confirmed state, meaning the breakout has occurred and the stock is trading above the critical structural support of $8.64. The current price of $12.05 represents a 9.2% extension from the entry point. The ATR at breakout was 3.1% (productive), and the current ATR is 2.9% (productive), indicating that volatility remains within a structural quality range suitable for position sizing. The setup is not invalidated; a close below $8.64 would be required to invalidate the structure.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Thesis: None named at this date.

As of 2026-06-13, there is no named macro or secular thesis driving this specific trade. This is a tactical, setup-led name. The conviction must be derived entirely from the quality of the structural setup (the confirmed coil) and the underlying business fundamentals reported in the most recent earnings and filings. No external macro narrative should be invented to support the position; the trade is justified by the alignment of price structure with the company's operational performance.

3. Business Overview

Company: BGC Group, Inc. Industry: Financial Services (Brokerage & Technology Solutions) Business Model: BGC operates as a global financial services enterprise facilitating transactions across a broad spectrum of asset classes, including fixed income, equities, energy commodities, and shipping. The company utilizes a hybrid model combining traditional voice brokerage with advanced electronic execution platforms.

Key Operational Highlights (as of Q1/Q2 2026):

• Revenue & Earnings Growth: In the earnings transcript dated 2026-05-07, management guided for Q2 revenues between $785 million and $845 million (vs. $784 million in 2025), representing 4% Q2 growth and 22% H1 growth. Adjusted pretax earnings were guided to $178 million–$196 million, implying 8% Q2 and 26% H1 growth.
• Cost Efficiency: The company has successfully executed a cost reduction program, building on a $25 million initiative to achieve $35 million in annualized cost savings.
• FMX UST Performance: The FMX UST business generated record quarterly ADV of $89.7 billion, a 51% increase year-over-year. Market share in this segment grew to 41% in Q1, up from 39% the prior quarter and 33% a year ago.
• ECS & Rates Growth: ECS revenues surged 120.1% to $330 million, driven by the acquisition of OTC and organic growth in energy and shipping. Rates revenues increased 27.5% to $256.2 million, supported by growth in listed futures, options, and interest rate swaps.
• Technology & Fenics: Fenics, the technology-driven business unit, is defined by high-margin electronic execution with expected pre-tax margins of at least 25%. The company reports a pipeline of new products in FX and fixed income expected to provide incremental growth.
• FMX Equity Partners: As of May 2026, FMX Holdings LLC (the electronic treasury forum) has a significant equity partnership with major financial institutions (Bank of America, Barclays, Citadel, etc.), who collectively invested $172 million for a 25.75% stake at a $667 million post-money valuation. These partners hold an additional 10.3% equity subject to volume targets.
• Product Launches: FMX Futures Exchange launched SOFR futures (Sept 2024) and U.S. Treasury futures (May 2025), expanding its electronic footprint in the largest notional futures contracts.

4. Archetype and Conviction

Archetype: Margin Inflector Rationale: The company fits the "Margin Inflector" archetype due to the successful transition toward high-margin, technology-driven execution (Fenics) and the strategic equity partnership with FMX. The evidence shows a clear shift from pure volume-based brokerage to a model where technology drives efficiency ($35M cost savings) and higher margins (Fenics margins >25%). The acquisition of OTC and the growth in ECS revenues further demonstrate the ability to inflect margins through strategic M&A and organic tech adoption.

Valuation & Conviction Stack:

• Thesis Strength: Moderate (Tactical, no macro tailwinds).
• Evidence Quality: High. Recent earnings (May 2026) and filings (March/May 2026) provide concrete data on revenue growth, margin expansion, and market share gains.
• Structural Quality: High. The ATR metrics (3.1% at breakout, 2.9% current) indicate a "productive" volatility environment, suggesting the stock is not in a chaotic or weak state.
• Rerating Potential: Moderate to High. The combination of 22% H1 revenue growth, 26% earnings growth, and the strategic FMX valuation ($667M) suggests the market may be re-rating the company from a traditional broker to a tech-enabled financial infrastructure play.

Financial Spine: Forward consensus EPS for FY1 is $1.42 and FY2 is $1.615, providing a complete coverage base for valuation analysis.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental Deterioration: A significant miss on the guidance provided in May 2026 (e.g., revenue growth turning negative or cost savings failing to materialize) would undermine the Margin Inflector thesis.
• FMX Performance: Failure by FMX Equity Partners to meet volume targets, potentially triggering a loss of the additional 10.3% equity stake or a devaluation of the FMX business.

Strengtheners:

• Continued Market Share Gains: Further expansion of FMX UST market share beyond the 41% level reported in Q1 2026.
• New Product Adoption: Successful launch and adoption of the "pipeline of new products" in FX and fixed income mentioned in the May 2026 transcript.
• Margin Expansion: Confirmation that Fenics margins remain above 25% and continue to expand as a percentage of total revenue.

Evidence Gaps:

• No Disconfirming Evidence: Currently, there is no missing evidence or disconfirming data points in the provided dataset.
• Long-term Sustainability: While short-term growth is strong, the evidence base (as of June 2026) does not yet contain multi-year data on the sustainability of the 120% ECS growth or the long-term impact of the FMX equity partnership on overall corporate margins beyond the immediate guidance period.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed active coil structure with price 9.2% above entry; Q1 2026 revenue guidance of $785-845M (22% H1 growth) and 26% earnings growth; FMX UST market share expansion to 41% and record ADV of $89.7B. Key risks: Price close below $8.64 invalidating the setup; failure to meet FMX volume targets affecting equity partner incentives; potential volatility spike exceeding current ATR norms. Sizing hint: Standard position sizing for a confirmed active coil with productive ATR; reduce size if extension exceeds 15% without new catalysts. Expected path: Management expectations of 13% organic growth and continued cost savings should support price stability; structural implications of FMX partnership suggest potential for multiple expansion if volume targets are met. Expected horizon: 3 to 6 months for the setup to play out relative to the next earnings cycle.